treating patients with gastric cancer with immunotherapy: who will benefit?
Published 2 years ago • 1.6K plays • Length 3:01Download video MP4
Download video MP3
Similar videos
-
3:18
immune checkpoint inhibitors and combination strategies for patients with gastric cancer
-
1:54
which patients with gastric cancer can benefit most from checkpoint inhibitors?
-
2:12
clinical trials investigating immunotherapy for gastric cancer
-
1:58
who benefits from immunotherapy in patients with advanced escc?
-
1:05
limitations in immune checkpoint inhibitors in treating gastric cancer
-
0:54
targeted treatment for gastric cancer beyond her2
-
47:26
treating stomach and gastrointestinal cancers with immunotherapy
-
1:00:33
immunotherapy and targeted therapies for gastric cancer patients webinar
-
3:01
genomic landscape of late-stage gastric cancer treated with pembrolizumab
-
3:15
pembrolizumab demonstrates promise in patients with pretreated metastatic gastric cancer
-
56:48
immunotherapy for gastroesophageal cancer
-
2:39
first line immunotherapy/chemotherapy in her2- gastric cancer in japan
-
2:29
overcoming resistance to immunotherapy as first-line therapy in gastric cancer
-
4:01
the role of immunotherapy in gastrointestinal cancers: an update from esmo
-
0:51
dr. deirdre cohen on when to treat gastric cancer patients with immunotherapies
-
1:14
dr. ahn on the role of immunotherapy in treating patients with gastric/gastroesophageal cancers
-
1:07:30
personalizing gastric cancer care with her2-targeted and other novel therapies
-
0:31
role of immunotherapy in gastric cancers
-
6:10
deliver: nivolumab in advanced gastric cancer